Literature DB >> 15716419

Hippocampal synaptic modulation by the phosphotyrosine adapter protein ShcC/N-Shc via interaction with the NMDA receptor.

Yoshiaki Miyamoto1, Ling Chen, Masahiro Sato, Masahiro Sokabe, Toshitaka Nabeshima, Tony Pawson, Ryuichi Sakai, Nozomu Mori.   

Abstract

N-Shc (neural Shc) (also ShcC), an adapter protein possessing two phosphotyrosine binding motifs [PTB (phosphotyrosine binding) and SH2 (Src homology 2) domains], is predominantly expressed in mature neurons of the CNS and transmits neurotrophin signals from the TrkB receptor to the Ras/mitogen-activated protein kinase (MAPK) pathway, leading to cellular growth, differentiation, or survival. Here, we demonstrate a novel role of ShcC, the modulation of NMDA receptor function in the hippocampus, using ShcC gene-deficient mice. In behavioral analyses such as the Morris water maze, contextual fear conditioning, and novel object recognition tasks, ShcC mutant mice exhibited superior ability in hippocampus-dependent spatial and nonspatial learning and memory. Consistent with this finding, electrophysiological analyses revealed that hippocampal long-term potentiation in ShcC mutant mice was significantly enhanced, with no alteration of presynaptic function, and the effect of an NMDA receptor antagonist on its expression in the mutant mice was notably attenuated. The tyrosine phosphorylation of NMDA receptor subunits NR2A and NR2B was also increased, suggesting that ShcC mutant mice have enhanced NMDA receptor function in the hippocampus. These results indicate that ShcC not only mediates TrkB-Ras/MAPK signaling but also is involved in the regulation of NMDA receptor function in the hippocampus via interaction with phosphotyrosine residues on the receptor subunits and serves as a modulator of hippocampal synaptic plasticity underlying learning and memory.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15716419      PMCID: PMC6725942          DOI: 10.1523/JNEUROSCI.3030-04.2005

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  15 in total

Review 1.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Authors:  Kawser Akter; Emily A Lanza; Stephen A Martin; Natalie Myronyuk; Melanie Rua; Robert B Raffa
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

Review 2.  Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.

Authors:  Mohammad A Kamal; Shubha Priyamvada; Arivarasu N Anbazhagan; Nasimudeen R Jabir; Shams Tabrez; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

Review 3.  Neurovascular Coupling in Type 2 Diabetes With Cognitive Decline. A Narrative Review of Neuroimaging Findings and Their Pathophysiological Implications.

Authors:  Mads C J Barloese; Christian Bauer; Esben Thade Petersen; Christian Stevns Hansen; Sten Madsbad; Hartwig Roman Siebner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-04       Impact factor: 6.055

Review 4.  Age matters.

Authors:  James Edgar McCutcheon; Michela Marinelli
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

Review 5.  The role of phosphoinositides in synapse function.

Authors:  Yoshibumi Ueda
Journal:  Mol Neurobiol       Date:  2014-06-17       Impact factor: 5.590

6.  Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex.

Authors:  Maile A Henson; Adam C Roberts; Kayvon Salimi; Swarooparani Vadlamudi; Robert M Hamer; John H Gilmore; L Fredrik Jarskog; Benjamin D Philpot
Journal:  Cereb Cortex       Date:  2008-02-21       Impact factor: 5.357

7.  RGS14 is a multifunctional scaffold that integrates G protein and Ras/Raf MAPkinase signalling pathways.

Authors:  Feng-jue Shu; Suneela Ramineni; John R Hepler
Journal:  Cell Signal       Date:  2010-03       Impact factor: 4.315

8.  Multi-locus genome-wide association analysis supports the role of glutamatergic synaptic transmission in the etiology of major depressive disorder.

Authors:  P H Lee; R H Perlis; J-Y Jung; E M Byrne; E Rueckert; R Siburian; S Haddad; C E Mayerfeld; A C Heath; M L Pergadia; P A F Madden; D I Boomsma; B W Penninx; P Sklar; N G Martin; N R Wray; S M Purcell; J W Smoller
Journal:  Transl Psychiatry       Date:  2012-11-13       Impact factor: 6.222

9.  Brain-derived neurotrophic factor modulation of Kv1.3 channel is disregulated by adaptor proteins Grb10 and nShc.

Authors:  Beverly S Colley; Melissa A Cavallin; Kc Biju; David R Marks; Debra A Fadool
Journal:  BMC Neurosci       Date:  2009-01-23       Impact factor: 3.288

10.  Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.

Authors:  A Gamir-Morralla; C López-Menéndez; S Ayuso-Dolado; G S Tejeda; J Montaner; A Rosell; T Iglesias; M Díaz-Guerra
Journal:  Cell Death Dis       Date:  2015-10-22       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.